Total circulating cell-free DNA as a prognostic biomarker in metastatic colorectal cancer before first-line oxaliplatin-based chemotherapy
Hamfjord, J., Guren, T.K., Dajani, O., Johansen, J.S., Glimelius, B., Sorbye, H., Pfeiffer, P., Lingjærde, O.C., Tveit, K.M., Kure, E.H., Pallisgaard, N., Spindler, K.-L.G.
Published in Annals of oncology (01.07.2019)
Published in Annals of oncology (01.07.2019)
Get full text
Journal Article
Elevated plasma YKL-40, lipids and lipoproteins, and ischemic vascular disease in the general population
Kjaergaard, A.D, Johansen, J.S, Bojesen, S.E, Nordestgaard, B.G
Published in Atherosclerosis (01.07.2015)
Published in Atherosclerosis (01.07.2015)
Get full text
Journal Article
Hepatic arterial infusion (HAI) of oxaliplatin with capecitabine in first line treatment of patients (pts) with liver limited metastases from colorectal cancer (LLmCRC)
Vittrup, B V, Nørgaard, H H, Bergenfeldt, M, Larsen, F O, Høgdall, E, Johansen, J S, Sidenius Johansen, J S, Hermann, H K, Nielsen, D L
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
2401 Dynamics of KRAS G12/13 allele burden in circulating tumor DNA predicts survival in patients with unresectable pancreatic cancer undergoing palliative chemotherapy
Johansen, J.S, Vibat, C.R.T, Hancock, S, Chen, I, Samuelsz, E, Collisson, E.A, Jensen, B.V, Melnikova, V, Erlander, M.G
Published in European journal of cancer (1990) (01.09.2015)
Published in European journal of cancer (1990) (01.09.2015)
Get full text
Journal Article
A Novel Pancreatic Cancer Mini-tumor Model to Study Desmoplasia and Myofibroblastic Cancer-Associated Fibroblast Differentiation
Harryvan, T.J., Hawinkels, L.J.A.C., Inderson, A., van Hooft, J.E., Micke, P., Johansen, J.S., van Wezel, T., Crobach, S., Baart, V.M., Quist, B.S., Roet, J.E.G., Kop, M.E., Östman, A., ten Dijke, P., Strell, C., Hornsveld, M.
Published in Gastro hep advances (2022)
Published in Gastro hep advances (2022)
Get full text
Journal Article
1945P Stroma-derived bIgH3 (βigH3/TGFBI) is the local mediator of pathological TGFβ activity in pancreatic cancer and a target to treat in patients with high fibrotic activity
Karsdal, M.A., Willumsen, N., Bager, C., Nissen, N.I., Teo Hansen Selnø, A., Mohamed, K.E., Pedersen, R.S., Chen, I., Johansen, J.S., Henriksen, K.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
Pre-treatment prediction of chemoresistance in second-line chemotherapy of ovarian carcinoma : value of serological tumor marker determination (tetranectin, YKL-40, CASA, CA 125)
GRONLUND, B, HØGDALL, E. V. S, CHRISTENSEN, I. J, JOHANSEN, J. S, NØRGAARD-PEDERSEN, B, ENGELHOLM, S. A, HØGDALL, C
Published in The International journal of biological markers (01.07.2006)
Published in The International journal of biological markers (01.07.2006)
Get full text
Journal Article
156P The association between fibrotic endotypes, determined by pre-treatment serum levels of collagen metabolites, and survival outcomes in patients with pancreatic cancer
Pedersen, R.S., Thorlacius-Ussing, J., Nissen, N.I., Johansen, A., Chen, I., Jensen, C., Hansen, C., Karsdal, M., Johansen, J.S., Willumsen, N.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
56P Serum protein signatures as potential novel diagnostic biomarkers for biliary tract cancer
Christensen, T.D., Maag, E., Larsen, O., Feltoft, C.L., Leerhøy, B., Chen, I.M., Hansen, C.P., Nielsen, D.L., Johansen, J.S.
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article
1685P COLAR: Results from an intervention study investigating IL-6 blockade with tocilizumab for treatment of immune checkpoint inhibitor induced colitis and arthritis
Holmstrøm, R.B., Nielsen, O.H., Jacobsen, S., Riis, L.B., Theile, S., Bjerrum, J.T., Vilmann, P., Johansen, J.S., Boisen, M.K., Eefsen, R.L., Svane, I.M., Nielsen, D., Chen, I.M.
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article
Circulating cell-free DNA as predictor of treatment failure after neoadjuvant chemo-radiotherapy before surgery in patients with locally advanced rectal cancer
Schou, J.V., Larsen, F.O., Sørensen, B.S., Abrantes, R., Boysen, A.K., Johansen, J.S., Jensen, B.V., Nielsen, D.L., Spindler, K.L.
Published in Annals of oncology (01.03.2018)
Published in Annals of oncology (01.03.2018)
Get full text
Journal Article
345P The prognostic value of pre-treatment circulating biomarkers of systemic inflammation (CRP, neutrophil-to-lymphocyte ratio, IL-6, and YKL-40) in vulnerable older patients with metastatic colorectal cancer: The randomized NORDIC9-study
Liposits, G., Skuladottir, H., Ryg, J., Winther, S.B., Möller, S., Hofsli, E., Shah, C-H., Poulsen Oestergaard, L., Berglund, A., Qvortrup, C., Osterlund, P.J., Johansen, J.S., Glimelius, B., Sorbye, H., Pfeiffer, P.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
High circulating miR-1247 is a marker for poor prognosis in patients with metastatic colorectal cancer treated with chemotherapy and cetuximab
Schou, J.V., Sztupinszki, Z., Johansen, J.S., Nielsen, D.L., Glimelius, B., Qvortrup, C., Sorbye, H., Jensen, B Vittrup, Pfeiffer, P.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
624P - High circulating miR-1247 is a marker for poor prognosis in patients with metastatic colorectal cancer treated with chemotherapy and cetuximab
Schou, J.V., Sztupinszki, Z., Johansen, J.S., Nielsen, D.L., Glimelius, B., Qvortrup, C., Sorbye, H., Jensen, B Vittrup, Pfeiffer, P.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
1539P Signature protein biomarkers in serum for diagnosis of pancreatic ductal adenocarcinoma
Lindgaard, S.C., Maag, E., Chen, I., Johansen, A.Z., Hansen, C.P., Hasselby, J.P., Jensen, B.V., Bojesen, S.E., Nielsen, K.R., Nielsen, D.L., Johansen, J.S.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
126P Prognostic value of blood-based fibrosis biomarkers in patients with metastatic colorectal cancer receiving chemotherapy and bevacizumab
Nissen, N.I., Kehlet, S., Boisen, M.K., Liljefors, M., Jensen, C., Johansen, A.Z., Johansen, J.S., Erler, J., Karsdal, M.A., Mortensen, J., Høye, A., Willumsen, N.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
Diagnostic analysis of patients referred from general practitioner with serious non-organ-specific symptoms and signs of cancer: A retrospective cohort study
Jørgensen, B.M., Dehlendorff, C., Kistorp, C.M.N., Bojesen, S.E., Johansen, J.S., Feltoft, C.L.
Published in Annals of oncology (01.09.2017)
Published in Annals of oncology (01.09.2017)
Get full text
Journal Article
PACTO: A single center, randomized, phase II study of the combination of nab-paclitaxel and gemcitabine with or without tocilizumab, an IL-6R inhibitor, as first-line treatment in patients with locally advanced or metastatic pancreatic cancer
Chen, I., Johansen, J.S., Zimmers, T.A., Dehlendorff, C., Kirk Parner, V., Vittrup Jensen, B., Nielsen, D.
Published in Annals of oncology (01.09.2017)
Published in Annals of oncology (01.09.2017)
Get full text
Journal Article